van der Burg M, Gennery AR. Educational paper. Eur J Pediatr. 2011;170(5):561. https://doi.org/10.1007/s00431-011-1452-3.

Article  PubMed  PubMed Central  Google Scholar 

Gelfand EW. SCID continues to point the way. N Engl J Med. 1990;322(24):1741–3. https://doi.org/10.1056/nejm199006143222410.

Article  PubMed  CAS  Google Scholar 

Worth AJ, Booth C, Veys P. Stem cell transplantation for primary immune deficiency. Curr Opin Hematol. 2013;20(6):501–8. https://doi.org/10.1097/MOH.0b013e328365a13b.

Article  PubMed  CAS  Google Scholar 

Niehues T, Perez-Becker R, Schuetz C. More than just SCID–the phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2. Clin Immunol. 2010;135(2):183–92. https://doi.org/10.1016/j.clim.2010.01.013.

Article  PubMed  CAS  Google Scholar 

Ru H, Chambers MG, Fu TM, Tong AB, Liao M, Wu H. Molecular mechanism of V(D)J recombination from synaptic RAG1-RAG2 complex structures. Cell. 2015;163(5):1138–52. https://doi.org/10.1016/j.cell.2015.10.055.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Villa A, Notarangelo LD. RAG gene defects at the verge of immunodeficiency and immune dysregulation. Immunol Rev. 2019;287(1):73–90. https://doi.org/10.1111/imr.12713.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Felfly H, Haddad GG. Hematopoietic stem cells: potential new applications for translational medicine. J Stem Cells. 2014;9(3):163–97.

PubMed  Google Scholar 

Yates F, Malassis-Séris M, Stockholm D, Bouneaud C, Larousserie F, Noguiez-Hellin P, et al. Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiency. Blood. 2002;100(12):3942–9. https://doi.org/10.1182/blood-2002-03-0782.

Article  PubMed  CAS  Google Scholar 

Bushman FD. Retroviral integration and human gene therapy. J Clin Invest. 2007;117(8):2083–6. https://doi.org/10.1172/jci32949.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cavazzana M, Six E, Lagresle-Peyrou C, André-Schmutz I, Hacein-Bey-Abina S. Gene therapy for X-linked severe combined immunodeficiency: where do we stand? Hum Gene Ther. 2016;27(2):108–16. https://doi.org/10.1089/hum.2015.137.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kohn LA, Kohn DB. Gene therapies for primary immune deficiencies. Front Immunol. 2021;12: 648951. https://doi.org/10.3389/fimmu.2021.648951.

Article  PubMed  PubMed Central  CAS  Google Scholar 

van Til NP, de Boer H, Mashamba N, Wabik A, Huston M, Visser TP, et al. Correction of murine Rag2 severe combined immunodeficiency by lentiviral gene therapy using a codon-optimized RAG2 therapeutic transgene. Mol Ther. 2012;20(10):1968–80. https://doi.org/10.1038/mt.2012.110.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Capo V, Castiello MC, Fontana E, Penna S, Bosticardo M, Draghici E, et al. Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation. J Allergy Clin Immunol. 2018;142(3):928-41e8. https://doi.org/10.1016/j.jaci.2017.11.015.

Article  PubMed  CAS  Google Scholar 

Gyurkocza B, Sandmaier BM. Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. Blood. 2014;124(3):344–53. https://doi.org/10.1182/blood-2014-02-514778.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lum SH, Hoenig M, Gennery AR, Slatter MA. Conditioning regimens for hematopoietic cell transplantation in primary immunodeficiency. Curr Allergy Asthma Rep. 2019;19(11):52. https://doi.org/10.1007/s11882-019-0883-1.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Steward CG, Jarisch A. Haemopoietic stem cell transplantation for genetic disorders. Arch Dis Child. 2005;90(12):1259. https://doi.org/10.1136/adc.2005.074278.

Article  PubMed  PubMed Central  CAS  Google Scholar 

McNerney ME, Godley LA, Le Beau MM. Therapy-related myeloid neoplasms: when genetics and environment collide. Nat Rev Cancer. 2017;17(9):513–27. https://doi.org/10.1038/nrc.2017.60.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Morton LM, Dores GM, Schonfeld SJ, Linet MS, Sigel BS, Lam CJK, et al. Association of Chemotherapy for solid tumors with development of therapy-related myelodysplastic syndrome or acute myeloid leukemia in the modern era. JAMA Oncol. 2019;5(3):318–25. https://doi.org/10.1001/jamaoncol.2018.5625.

Article  PubMed  Google Scholar 

Overbeek A, van den Berg MH, van Leeuwen FE, Kaspers GJL, Kremer LCM, Lambalk CB, et al. Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood cancer and cancer in the reproductive age. Cochrane Database Syst Rev. 2019;2019(4):CD009127. https://doi.org/10.1002/14651858.CD009127.pub2.

Article  PubMed Central  Google Scholar 

Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15(12):1628–33. https://doi.org/10.1016/j.bbmt.2009.07.004.

Article  PubMed  PubMed Central  Google Scholar 

Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck JM, et al. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. Blood. 2017;130(25):2718–27. https://doi.org/10.1182/blood-2017-05-781849.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cancrini C, Ferrua F, Scarselli A, Brigida I, Romiti ML, Barera G, et al. Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID. Haematologica. 2010;95(10):1778–82. https://doi.org/10.3324/haematol.2010.025098.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Iguchi A, Kawamura N, Kobayashi R, Takezaki SI, Ohkura Y, Inamoto J, et al. Successful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID. Bone Marrow Transplant. 2011;46(12):1526–31. https://doi.org/10.1038/bmt.2010.338.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, et al. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Blood. 2018;132(17):1737–49. https://doi.org/10.1182/blood-2018-03-840702.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Neven B, Leroy S, Decaluwe H, Le Deist F, Picard C, Moshous D, et al. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood. 2009;113(17):4114–24. https://doi.org/10.1182/blood-2008-09-177923.

Article  PubMed  CAS  Google Scholar 

Huston MW, Riegman AR, Yadak R, van Helsdingen Y, de Boer H, van Til NP, et al. Pretransplant mobilization with granulocyte colony-stimulating factor improves B-cell reconstitution by lentiviral vector gene therapy in SCID-X1 mice. Hum Gene Ther. 2014;25(10):905–14. https://doi.org/10.1089/hum.2014.101.

Article  PubMed  PubMed Central  CAS  Google Scholar